当前位置:首页 - 行情中心 - 三诺生物(300298) - 财务分析 - 现金流量表

三诺生物

(300298)

  

流通市值:78.26亿  总市值:97.15亿
流通股本:4.51亿   总股本:5.60亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,640,108,982.042,314,897,963.051,176,327,131.634,352,894,977.11
  收到的税费返还36,665,596.8732,707,979.7831,872,657.5684,453,205.54
  收到其他与经营活动有关的现金41,995,812.4630,888,700.9812,876,595.7956,637,208.04
  经营活动现金流入小计3,718,770,391.372,378,494,643.811,221,076,384.984,493,985,390.69
  购买商品、接受劳务支付的现金1,254,446,571.76831,951,659.65397,118,598.291,574,703,161.62
  支付给职工以及为职工支付的现金919,419,480.46630,306,905.15313,436,706.111,084,582,640.49
  支付的各项税费208,583,504.18148,759,718.982,091,472.56281,150,922.96
  支付其他与经营活动有关的现金799,091,861.31494,111,528.48231,350,988.14922,259,766.45
  经营活动现金流出小计3,181,541,417.712,105,129,812.181,023,997,765.13,862,696,491.52
  经营活动产生的现金流量净额537,228,973.66273,364,831.63197,078,619.88631,288,899.17
二、投资活动产生的现金流量:
  收回投资收到的现金34,452,466.0224,116,726.2124,116,726.2185,683,300
  取得投资收益收到的现金1,154,018.21831,286.13575,874.591,135,959.66
  处置固定资产、无形资产和其他长期资产收回的现金净额54,649.615,285.957,565.6635,053.57
  收到的其他与投资活动有关的现金929,194,855.15545,843,936.97289,463,874.19404,198,233.36
  投资活动现金流入小计964,855,988.98570,807,235.26314,164,040.59491,652,546.59
  购建固定资产、无形资产和其他长期资产支付的现金155,758,536.5127,379,358.1349,873,378.86186,668,722.05
  支付其他与投资活动有关的现金1,082,815,470.03494,101,866.61219,472,650.34480,000,000
  投资活动现金流出小计1,238,574,006.53621,481,224.74269,346,029.2666,668,722.05
  投资活动产生的现金流量净额-273,718,017.55-50,673,989.4844,818,011.39-175,016,175.46
三、筹资活动产生的现金流量:
  取得借款收到的现金288,150,542.75149,435,572.6595,764,138.73154,444,750.02
  收到其他与筹资活动有关的现金---77,070,000
  筹资活动现金流入小计288,150,542.75149,435,572.6595,764,138.73231,514,750.02
  偿还债务支付的现金292,770,692.47252,000,000245,000,000413,966,000
  分配股利、利润或偿付利息支付的现金125,138,472.5123,146,682.61900,836.8132,189,521.63
  支付其他与筹资活动有关的现金140,277,183.1188,769,928.824,385,526.669,632,746.39
  筹资活动现金流出小计558,186,348.08463,916,611.43250,286,363.4615,788,268.02
  筹资活动产生的现金流量净额-270,035,805.33-314,481,038.78-154,522,224.67-384,273,518
四、汇率变动对现金及现金等价物的影响-1,918,721.911,870,204.87577,999.3-9,210,729.26
五、现金及现金等价物净增加额-8,443,571.13-89,919,991.7687,952,405.962,788,476.45
  加:期初现金及现金等价物余额842,454,892.22842,454,892.22841,462,707.35779,666,415.77
  期末现金及现金等价物余额834,011,321.09752,534,900.46929,415,113.25842,454,892.22
补充资料:
  净利润-182,071,127.84-345,854,598.97
  资产减值准备--3,859,586.47-74,396,452.82
  固定资产和投资性房地产折旧-68,589,588.51-149,914,792.45
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-68,589,588.51-149,914,792.45
  无形资产摊销-20,809,759.48-50,474,766.9
  长期待摊费用摊销-2,599,615.03-5,535,090.2
  处置固定资产、无形资产和其他长期资产的损失-325,746.84--957,336.24
  财务费用-18,799,668.78-48,132,581.04
  投资损失--825,810.72-1,595,366.95
  递延所得税-47,192.6--4,497,711.4
  其中:递延所得税资产减少--299,478.65--1,490,560.18
    递延所得税负债增加-346,671.25--3,007,151.22
  存货的减少--45,761,721.73--34,161,589.23
  经营性应收项目的减少--75,065,319.29--156,399,233.44
  经营性应付项目的增加-97,999,960.35-107,870,131.92
  现金的期末余额-752,534,900.46-842,454,892.22
  减:现金的期初余额-842,454,892.22-779,666,415.77
  现金及现金等价物的净增加额--89,919,991.76-62,788,476.45
公告日期2025-10-242025-08-282025-04-292025-04-21
审计意见(境内)标准无保留意见
TOP↑